Quality Assurance Group, Early Detection and Prevention Section, International Agency for Research on Cancer, Lyon, France.
Salud Publica Mex. 2013 May-Jun;55(3):318-28. doi: 10.21149/spm.v55i3.7215.
In Europe, as in many other regions of the world, breast cancer is a major cause of suffering and death. Early detection of breast cancer by systematic mammography screening can find lesions for which treatment is more effective and generally more favourable for quality of life. Comprehensive quality assurance guidelines for breast cancer screening based on mammography have been developed in the Europe Against Cancer programme with the aim of maximising screening benefits while minimising adverse effects, such as unnecessary examination or treatment resulting from false-positive screening tests. The present report provides an overview of the European experience in developing and implementing quality assurance guidelines for breast cancer screening. It highlights implications relevant to those regions of the world in which the burden of breast cancer in the coming years will make population-based screening an option for cancer control.
在欧洲,如同世界上许多其他地区一样,乳腺癌是导致痛苦和死亡的主要原因之一。通过系统的乳房 X 光筛查早期发现乳腺癌,可以找到更有效的治疗方法,通常对生活质量也更有利。欧洲抗癌计划制定了基于乳房 X 光的乳腺癌筛查综合质量保证指南,旨在最大限度地提高筛查效益,同时将不必要的检查或因假阳性筛查测试而导致的治疗等不良影响降到最低。本报告概述了欧洲在制定和实施乳腺癌筛查质量保证指南方面的经验。它强调了对那些在未来几年乳腺癌负担将使基于人群的筛查成为癌症控制选择的世界区域具有重要意义的影响。